1. Home
  2. Analysis
  3. Clonidine
  4. Red-cell-aplasia

Clonidine and Red cell aplasia - a phase IV clinical study of FDA data

Summary:

Red cell aplasia is reported as a side effect among people who take Clonidine (clonidine), especially for people who are male, 30-39 old, also take Eprex, and have Chronic renal failure.

The phase IV clinical study analyzes which people have Red cell aplasia when taking Clonidine. It is created by eHealthMe based on reports of 63,883 people who have side effects when taking Clonidine from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

What is Red cell aplasia?

Red cell aplasia (a type of anaemia affecting the precursors to red blood cells) is found to be associated with 117 drugs and 34 conditions by eHealthMe. Check the latest studies of Red cell aplasia.

On Jul, 08, 2026

63,883 people reported to have side effects when taking Clonidine.
Among them, 42 people (0.07%) have Red cell aplasia.

Could Clonidine cause Red cell aplasia?

Among these 42 people:

What is the gender of people who have Red cell aplasia when taking Clonidine? *

  • female: 14.29 %
  • male: 85.71 %

What is the age of people who have Red cell aplasia when taking Clonidine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.5 %
  • 30-39: 42.5 %
  • 40-49: 5.0 %
  • 50-59: 10.0 %
  • 60+: 40.0 %

What are other drugs people take besides Clonidine? *

  1. Eprex: 33 people, 78.57%
  2. Norvasc: 25 people, 59.52%
  3. Minoxidil: 9 people, 21.43%
  4. Altace: 9 people, 21.43%
  5. Omeprazole: 9 people, 21.43%
  6. Aldomet: 8 people, 19.05%
  7. Lasix: 8 people, 19.05%
  8. Ventolin: 7 people, 16.67%
  9. Atarax: 7 people, 16.67%
  10. Monopril: 7 people, 16.67%

What are other side effects people have besides Red cell aplasia? *

  1. Drug Ineffective: 23 people, 54.76%
  2. Anti-Erythropoietin Antibody Positive: 19 people, 45.24%
  3. Thrombocytopenia (decrease of platelets in blood): 8 people, 19.05%
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 16.67%
  5. Dyspnea Exacerbated: 5 people, 11.90%
  6. Nosebleed (bleeding from nose): 5 people, 11.90%
  7. Aplastic Anemia: 5 people, 11.90%
  8. Haemoglobin Decreased: 4 people, 9.52%
  9. Antineutrophil Cytoplasmic Antibody Positive: 4 people, 9.52%
  10. Thymus Hypertrophy (extra growth of thymus): 4 people, 9.52%

What are the existing conditions these people have? *

  1. Chronic Renal Failure (kidney failure): 8 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and have Red cell aplasia?

- Check whether Red cell aplasia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clonidine:

Red cell aplasia treatments and more:

How severe was Red cell aplasia and when was it recovered:

Expand to all the drugs that have ingredients of clonidine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Red cell aplasia:

Browse all the conditions that are associated with Red cell aplasia:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.